Issn Print: 0195-668X
Publication Date: 2017/05/19
Reduction of LDL-C-related residual cardiovascular risk with ezetimibe: are mechanistic considerations warranted in practice?
Karin H. Humphries; G.B. John Mancini
Author Information: University of British Columbia, Division of Cardiology, Vancouver, Canada
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.